Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials).
This article discusses the key symptom domains to be assessed in fibromyalgia. Development of a consensus on a core set of outcome measures that should be assessed and reported in all clinical trials is needed to facilitate interpretation, pooling, and comparison of results. This aligns with the key objective of the Outcome Measures in Rheumatoid Arthritis Clinical Trials initiative to improve outcome measurement in rheumatic diseases through a data-driven interactive consensus process.
Choy
Ernest H
EH
Sir Alfred Baring Garrod Clinical Trials Unit, Academic Department Rheumatology, Weston Education Centre, King's College London, Cutcombe Road, London, UK. ernest.choy@kcl.ac.uk
Mease
Philip J
PJ
D001172:Arthritis, Rheumatoid / Q000628:therapy; D002986:Clinical Trials as Topic / Q000379:methods*; D003697:Delphi Technique; D005356:Fibromyalgia / Q000503:physiopathology* / Q000628:therapy*; D017144:Focus Groups; D006801:Humans; D016896:Treatment Outcome